SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is currently trending due to a wave of positive analyst coverage, including a new Buy rating and price target from Wedbush, coupled with intense speculation regarding its unique position as the only pure-play neutral-atom quantum company involved in recent high-level government executive orders. The community is actively debating the stock's long-term potential in the defense and space sectors while navigating frustration over volatility and the impact of significant short interest on recent price action.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is seeing intense trading activity as investors position themselves ahead of upcoming quarterly delivery reports, with community members fiercely debating whether the stock's recent surge reflects genuine growth or a temporary rally fueled by options-driven speculation. The conversation is dominated by contrasting sentiment, where bulls are betting on a major breakout supported by potential delivery beats, while skeptics warn of significant downside risk and label the current valuation as disconnected from fundamentals.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is facing significant selling pressure and negative sentiment, driven largely by reports that hyperscalers like Meta are exploring the commercialization of their own excess AI compute capacity. Shareholders are actively debating the company's long-term viability, expressing mounting frustration over persistent price declines and concerns regarding management's capital allocation and lack of major deal announcements.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is currently the center of intense debate as traders weigh the potential market impacts of the EU's MiCA deadline against ongoing volatility in crypto and broader tech sector rotations. While some community members point to the stock's role as critical infrastructure for institutional stablecoin projects as a long-term catalyst, others remain sharply focused on short-term technical resistance and persistent downward price action.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently surging as investors bet on potential upcoming catalysts, including global expansion efforts and positive clinical trial momentum involving the company's immunotherapy platform. The community is actively discussing a possible short squeeze, fueled by heavy options activity and high short interest, while celebrating recent media exposure highlighting the potential of NK cell therapies.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending due to a combination of high short interest and a small public float, fueling intense retail speculation about its potential as a short-squeeze candidate. Community members are actively debating the viability of this squeeze thesis while comparing it to other restaurant-sector plays and emphasizing the importance of risk management when navigating high-volatility setups.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is facing heightened investor attention as the stock navigates a complex environment of resilient premium travel demand against significant headwinds from volatile jet fuel costs and geopolitical tensions. Market participants are actively debating the company's ability to maintain margin strength through pricing power and capacity adjustments while monitoring institutional positioning and institutional momentum during this period of high industry uncertainty.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is experiencing significant market interest as it advances a merger with Agility Robotics, a company gaining attention as a pure-play leader in humanoid robotics supported by major tech backers like Amazon and NVIDIA. The community is actively discussing the stock's potential for long-term commercialization and supply chain dominance, while weighing the inherent risks and volatility typically associated with the SPAC merger process.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently trending as investors focus on its strategic manufacturing joint venture with Toyota, which aims to scale production of the company's electric air taxis. While the community is actively debating the potential for long-term production advantages versus concerns over cash burn and stock dilution, sentiment is divided between those holding for a commercial inflection point and traders reacting to intraday volatility and high short interest.

ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

ProShares UltraShort Bloomberg Natural Gas ($KOLD) is currently seeing heightened activity as traders react to the ongoing volatility in natural gas futures, driven by EIA storage data and uncertainty surrounding production levels and weather forecasts. The community is actively debating the merits of trading highly leveraged inverse instruments versus the underlying commodity, with many highlighting the risks of structural decay while others look to capitalize on sharp intraday price swings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Zymeworks Inc. (ZYME) Stock an Undervalued Biotech Opportunity With Oncology Growth Ahead?

Is Zymeworks Inc. (ZYME) Stock an Undervalued Biotech Opportunity With Oncology Growth Ahead...

Theravance Stock Down 3% After Zymeworks Announces Buyout

TBPH falls after agreeing to a $929 million all-cash acquisition by Zymeworks, following a strategic review triggered by its failed ampreloxetine program.

Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition

Zymeworks will acquire Theravance Biopharma for $929 million, adding YUPELRI cash flows and expanding its portfolio.read more...

Zymeworks To Buy Theravance Biopharma In $929M Deal – A Look At What This Deal Means For TBPH Shareholders

Equity

Theravance Biopharma shareholders will receive a contingent value right (CVR) under which they will get 80% of the net proceeds from any future license, divestiture, or monetization of ampreloxetine over the next ten years.


Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery

Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery PR Newswire VANCOUVER, BC, June 18, 2026 Vancouver-based biotech companies Gandeeva Therapeutics and Zymeworks have partnered to generate cryo-EMbased...

Zymeworks (ZYME) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates

Zymeworks (ZYME) delivered earnings and revenue surprises of -510.13% and -94.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates

uniQure (QURE) delivered earnings and revenue surprises of +2.86% and -48.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Pictet Asset Management Holding SA Invests $1.97 Million in Zymeworks Inc. $ZYME

Pictet Asset Management Holding SA purchased a new position in shares of Zymeworks Inc. (NASDAQ:ZYME - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing...

Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Beat Estimates

Vertex (VRTX) delivered earnings and revenue surprises of +5.76% and +0.19%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

Zymeworks BC Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ZYMEZymeworks Inc

Fundamentals

Latest ZYME News